Menu

• Ask a Health Expert about HEPATIC LESION
• Post Your Side Effect related to HEPATIC LESION
• HEPATIC LESION and FDA Warnings
• HEPATIC LESION in Patients Wiki
• Report HEPATIC LESION in Drug Side Effect Survey

HEPATIC LESION side effect

What is HEPATIC LESION ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Taxotere Side Effects Report #5674824-7
Health Professional from UNITED STATES reported TAXOTERE problem on Mar 14, 2008. Male patient, 72 years of age, weighting 165.8 lb, was diagnosed with pain and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: hepatic lesion, . TAXOTERE dosage: unknown. During the same period patient was treated with LONAFARNIB, DEXAMETHASONE, ACETAMINOPHEN, OXYCODONE, SYNTHROID, OMEPRAZOLE, ADVAIR DISKUS, ALBUTEROL. Patient was hospitalized. Patient recovered.

Rapamune Side Effects Report #5581989-4
RAPAMUNE problem was reported by a Health Professional from UNITED KINGDOM on Dec 31, 2007. Female patient, weighting 123.5 lb, was diagnosed with renal transplant and was treated with RAPAMUNE. After drug was administered, patient experienced the following problems/side effects: hepatic lesion, splenic lesion, . RAPAMUNE dosage: unknown. During the same period patient was treated with PREDNISOLONE, ATORVASTATIN CALCIUM, LANSOPRAZOLE, PERINDOPRIL, ALFACALCIDOL, CALCICHEW, FEMSEVEN, ACETYLSALICYLIC ACID SRT. Patient recovered.

Levora Side Effects Report #5547264-9
Consumer or non-health professional from SPAIN reported LEVORA problem on Nov 30, 2007. Female patient, 45 years of age, was diagnosed with oral contraception and was treated with LEVORA. After drug was administered, patient experienced the following problems/side effects: hepatic lesion, peliosis hepatis, . LEVORA dosage: unknown. Patient recovered.

Prograf Side Effects Report #5469703-4
PROGRAF problem was reported by a Physician from GERMANY on Sept 18, 2007. Male patient, weighting 229.3 lb, was diagnosed with prophylaxis against transplant rejection, hypertension, cholelithiasis and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: hepatic lesion, . PROGRAF dosage: 1 MG TABLET/ 11/2-0-1. During the same period patient was treated with PANTOPRAZOLE, METOPROLOL SUCCINATE, URSO FALK, ENALAPRIL MALEATE, CELLCEPT, AMLODIPINE. Patient was hospitalized. Patient recovered.


Humira Side Effects Report #5390931-0
Physician from UNITED STATES reported HUMIRA problem on July 12, 2007. Male patient, 76 years of age, was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: hepatic lesion, neoplasm malignant, . HUMIRA dosage: unknown. Patient died on 01/01/2003.

Humira Side Effects Report #5390931-0
HUMIRA problem was reported by a Physician from UNITED STATES on July 12, 2007. Male patient, 76 years of age, was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: hepatic lesion, neoplasm malignant, . HUMIRA dosage: unknown. Patient died on 01/01/2003.

Thalidomide Side Effects Report #5794517-5
Health Professional from reported THALIDOMIDE problem on June 12, 2008. Female patient was diagnosed with myelodysplastic syndrome and was treated with THALIDOMIDE. After drug was administered, patient experienced the following problems/side effects: hepatic lesion, nephropathy toxic, . THALIDOMIDE dosage: 200-400 MG, DAILY; ORAL. During the same period patient was treated with CYCLOSPORINE. Patient recovered.

Prozac Side Effects Report #5706553-5
PROZAC problem was reported by a Physician from CHINA on Apr 01, 2008. Male patient was diagnosed with depression and was treated with PROZAC. After drug was administered, patient experienced the following problems/side effects: hepatic lesion, jaundice, . PROZAC dosage: 20 MG, DAILY (1/D). Patient recovered.

Citalopram Side Effects Report #5361357-0
Health Professional from SPAIN reported CITALOPRAM HYDROBROMIDE problem on May 30, 2007. Male patient, 68 years of age, was treated with CITALOPRAM HYDROBROMIDE. After drug was administered, patient experienced the following problems/side effects: hepatic lesion, . CITALOPRAM HYDROBROMIDE dosage: 20 MG QD PO. During the same period patient was treated with ARICEPT. Patient recovered.


Leflunomide Side Effects Report #5652175-4
LEFLUNOMIDE problem was reported by a Consumer or non-health professional from FRANCE on Feb 18, 2008. Female patient, 34 years of age, was diagnosed with juvenile arthritis, therapeutic procedure and was treated with LEFLUNOMIDE. After drug was administered, patient experienced the following problems/side effects: hepatic fibrosis, hepatic lesion, hepatic necrosis, hepatitis fulminant, hepatomegaly, hepatotoxicity, vitamin k deficiency, . LEFLUNOMIDE dosage: 20 MG/DAY. During the same period patient was treated with CHOLESTYRAMINE, ACETAMINOPHEN W. Patient was hospitalized. Patient recovered.

Humira Side Effects Report #5654075-2
Health Professional from UNITED KINGDOM reported HUMIRA problem on Feb 26, 2008. Female patient, weighting 114.6 lb, was diagnosed with rheumatoid arthritis and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: disseminated tuberculosis, hepatic lesion, infection, lung neoplasm, malaise, spleen disorder, . HUMIRA dosage: unknown. During the same period patient was treated with SULFASALAZINE, METHOTREXATE, PARAMOL, ETODOLAC, FOLIC ACID. Patient was hospitalized. Patient recovered.

Avonex Side Effects Report #5671012-5
AVONEX problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 03, 2008. Female patient, 51 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis, hepatic lesion, kidney small, renal artery stenosis, thrombosis, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.

Secalip Side Effects Report #5619137-4
Physician from GERMANY reported SECALIP problem on Jan 30, 2008. Male patient, 40 years of age, was diagnosed with hypercholesterolaemia, immunisation and was treated with SECALIP. After drug was administered, patient experienced the following problems/side effects: congenital cystic kidney disease, hepatic lesion, renal failure chronic, rhabdomyolysis, . SECALIP dosage: unknown. During the same period patient was treated with HEPATITIS B SURFACE ANTIGEN, INFLUENZA VIRUS VACCINE POLYVALENT, INFLUENZA VIRUS VACCINE POLYVALENT, INFLUENZA VIRUS VACCINE POLYVALENT. Patient was hospitalized. Patient recovered.

Lamisil Side Effects Report #5419271-8
LAMISIL problem was reported by a Physician from GERMANY on Aug 17, 2007. Female patient, 57 years of age, weighting 130.1 lb, was diagnosed with onychomycosis and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: hepatic lesion, intestinal operation, neuroendocrine carcinoma, . LAMISIL dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.


Lamisil Side Effects Report #5419275-5
Physician from GERMANY reported LAMISIL problem on Aug 17, 2007. Female patient, 57 years of age, weighting 130.1 lb, was diagnosed with onychomycosis and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: hepatic lesion, intestinal operation, neuroendocrine carcinoma, . LAMISIL dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.

Femara Side Effects Report #5379655-3
FEMARA problem was reported by a Physician from ITALY on June 25, 2007. Female patient, 73 years of age, was diagnosed with breast cancer and was treated with FEMARA. After drug was administered, patient experienced the following problems/side effects: gastric cancer, hepatic lesion, hepatic mass, . FEMARA dosage: 2.5 MG/D. Patient recovered.

Femara Side Effects Report #5381726-2
Consumer or non-health professional from ITALY reported FEMARA problem on June 29, 2007. Female patient, 73 years of age, was diagnosed with breast cancer and was treated with FEMARA. After drug was administered, patient experienced the following problems/side effects: gastric cancer, hepatic lesion, hepatic mass, . FEMARA dosage: 2.5 MG/D. Patient recovered.

Femara Side Effects Report #5379655-3
FEMARA problem was reported by a Physician from ITALY on June 25, 2007. Female patient, 73 years of age, was diagnosed with breast cancer and was treated with FEMARA. After drug was administered, patient experienced the following problems/side effects: gastric cancer, hepatic lesion, hepatic mass, . FEMARA dosage: 2.5 MG/D. Patient recovered.

Femara Side Effects Report #5381726-2
Consumer or non-health professional from ITALY reported FEMARA problem on June 29, 2007. Female patient, 73 years of age, was diagnosed with breast cancer and was treated with FEMARA. After drug was administered, patient experienced the following problems/side effects: gastric cancer, hepatic lesion, hepatic mass, . FEMARA dosage: 2.5 MG/D. Patient recovered.


Thalomid Side Effects Report #5766743-2
THALOMID problem was reported by a Physician from UNITED STATES on May 28, 2008. Female patient, 76 years of age, was diagnosed with pancreatic carcinoma and was treated with THALOMID. After drug was administered, patient experienced the following problems/side effects: gastric dilatation, hepatic lesion, hepatic mass, kidney fibrosis, lymphopenia, malignant neoplasm progression, neuropathy peripheral, opportunistic infection, pancreatic mass, . THALOMID dosage: 50 MG, 1 IN 1 D, ORAL; 250 MG, QD, DAYS 1-7, 15-21 Q28 DAYS X2 CYCLES. During the same period patient was treated with TEMODAR. Patient recovered.

Humira Side Effects Report #5695172-5
Consumer or non-health professional from UNITED STATES reported HUMIRA problem on Mar 26, 2008. Female patient, weighting 118.1 lb, was diagnosed with crohn's disease and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, hepatic lesion, palpatory finding abnormal, rectal abscess, . HUMIRA dosage: unknown. Patient was hospitalized. Patient recovered.

Femara Side Effects Report #5375212-3
FEMARA problem was reported by a Physician from ITALY on June 20, 2007. Female patient, 73 years of age, was diagnosed with breast cancer and was treated with FEMARA. After drug was administered, patient experienced the following problems/side effects: gastric cancer, hepatic lesion, hepatic mass, . FEMARA dosage: unknown. Patient recovered.

Mycophenolate Side Effects Report #5327256-5
Health Professional from AUSTRALIA reported MYCOPHENOLATE MOFETIL problem on May 08, 2007. Male patient, 36 years of age, was treated with MYCOPHENOLATE MOFETIL. After drug was administered, patient experienced the following problems/side effects: epstein-barr viraemia, hepatic lesion, liver function test abnormal, lung neoplasm, lymphocyte count abnormal, lymphoproliferative disorder, non-hodgkin's lymphoma, ureteric operation, ureteric stenosis, . MYCOPHENOLATE MOFETIL dosage: unknown. During the same period patient was treated with TACROLIMUS, PREDNISONE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.

Zelnorm Side Effects Report #5339736-7
ZELNORM problem was reported by a Consumer or non-health professional from UNITED STATES on May 22, 2007. Female patient, 43 years of age, was diagnosed with irritable bowel syndrome and was treated with ZELNORM. After drug was administered, patient experienced the following problems/side effects: abdominal pain, hepatic lesion, hepatic neoplasm, hepatic steatosis, . ZELNORM dosage: unknown. Patient recovered.

Prograf Side Effects Report #5343630-5
Health Professional from AUSTRALIA reported PROGRAF problem on May 15, 2007. Male patient, 36 years of age, was diagnosed with transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus antibody positive, hepatic lesion, liver function test abnormal, lung neoplasm, lymphoproliferative disorder, non-hodgkin's lymphoma, ureteric stenosis, . PROGRAF dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, PREDNISONE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.

Dasatinib Side Effects Report #5262564-8
DASATINIB problem was reported by a Consumer or non-health professional from AUSTRALIA on Mar 05, 2007. Male patient, 66 years of age, was diagnosed with chronic myeloid leukaemia and was treated with DASATINIB. After drug was administered, patient experienced the following problems/side effects: dyspnoea, hepatic lesion, pleural effusion, . DASATINIB dosage: unknown. Patient was hospitalized. Patient recovered.

Byetta Side Effects Report #5285913-3
Consumer or non-health professional from UNITED STATES reported BYETTA problem on Mar 14, 2007. Male patient, 66 years of age, weighting 220.0 lb, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: coronary arterial stent insertion, hepatic lesion, renal neoplasm, . BYETTA dosage: unknown. During the same period patient was treated with GLUCOPHAGE, GLYBURIDE, TRICOR, PLAVIX, FUROSEMIDE, LIPITOR, ATENOLOL. Patient was hospitalized. Patient recovered.

Valacyclovir Side Effects Report #5653409-2
VALACYCLOVIR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 03, 2008. Female patient, 53 years of age, was treated with VALACYCLOVIR. After drug was administered, patient experienced the following problems/side effects: ear infection, headache, hepatic lesion, lymphadenopathy, panic attack, pruritus, sarcoidosis, . VALACYCLOVIR dosage: 500MG TWICE PER DAY. Patient recovered.

Versed Side Effects Report #5553887-3
Pharmacist from UNITED STATES reported VERSED problem on Dec 12, 2007. Female patient, 67 years of age, was treated with VERSED. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, erythema, hepatic lesion, hypertension, hypotension, labile blood pressure, liver function test abnormal, . VERSED dosage: unknown. During the same period patient was treated with FENTANYL. Patient was hospitalized. Patient recovered.

Telithromycin Side Effects Report #5573038-9
TELITHROMYCIN problem was reported by a Consumer or non-health professional from GREECE on Dec 19, 2007. Female patient, 66 years of age, was diagnosed with hypertension and was treated with TELITHROMYCIN. After drug was administered, patient experienced the following problems/side effects: chromaturia, fatigue, hepatic lesion, jaundice, . TELITHROMYCIN dosage: unknown. During the same period patient was treated with IRBESARTAN. Patient was hospitalized. Patient recovered.

Sirolimus Side Effects Report #5477901-9
Health Professional from AUSTRALIA reported SIROLIMUS problem on Oct 02, 2007. Female patient, 67 years of age, was diagnosed with renal transplant and was treated with SIROLIMUS. After drug was administered, patient experienced the following problems/side effects: axillary mass, blood creatinine increased, hepatic lesion, liver function test abnormal, metastases to bone marrow, neuroendocrine carcinoma of the skin, oedema peripheral, . SIROLIMUS dosage: unknown. During the same period patient was treated with PREDNISOLONE, CICLOSPORIN. Patient died.

Tegretol Side Effects Report #5347212-0
TEGRETOL problem was reported by a Pharmacist from UNITED STATES on Oct 04, 2006. Female patient, 31 years of age, was diagnosed with convulsion and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: chills, granuloma, hepatic lesion, hypersensitivity, pyrexia, splenic lesion, . TEGRETOL dosage: 200 MG, BID. Patient was hospitalized. Patient recovered.

Fludarabine Side Effects Report #5299037-2
Health Professional from UNITED STATES reported FLUDARABINE PHOSPHATE problem on Apr 12, 2007. Male patient, weighting 200.4 lb, was diagnosed with bone marrow conditioning regimen and was treated with FLUDARABINE PHOSPHATE. After drug was administered, patient experienced the following problems/side effects: ascites, gallbladder disorder, hepatic lesion, hepatosplenomegaly, liver function test abnormal, lymphadenopathy, pelvic fluid collection, . FLUDARABINE PHOSPHATE dosage: unknown. During the same period patient was treated with CAMPATH, BUSULFAN. Patient was hospitalized. Patient recovered.